NCT02348307View on ClinicalTrials.gov

Single Dose Phase I Study of FYU-981

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy
Interventions
DRUG

FYU-981, (Oral single dosing)

Subjects randomized to the FYU-981 arm receive active drug, FYU-981.

DRUG

Placebo, (Oral single dosing)

Subjects randomized to the placebo arm receive placebo.

Trial Locations (1)

Unknown

Japan, Tokyo

Sponsors
All Listed Sponsors
lead

Fuji Yakuhin Co., Ltd.

INDUSTRY